Publications - 2011
Mise à jour : 05/03/2012 - BioDoc
Allain P, Gaura V, Fasotti L, Chauvire V, Prundean A, Sherer-Gagou C, Bonneau D, Bachoud-Levi A C, Dubas F, Remy P, Le Gall D, Verny C. (2011).
The neural substrates of script knowledge deficits as revealed by a PET study in Huntington's disease.
Neuropsychologia. 49: 2673-2684. IF:03.949 [I2BM/SHFJ]
Angeard N, Jacquette A, Gargiulo M, Radvanyi H, Moutier S, Eymard B, Heron D. (2011).
A new window on neurocognitive dysfunction in the childhood form of myotonic dystrophy type 1 (DM1).
Neuromusc Disord. 21: 468-476. IF:02,764 [I2BM/SHFJ I2BM/CI-NAPS]
Artiges E, Leroy C, Pepin A, De Beaurepaire R, Beaufils B, Gruel N, Korwin J P, Galinowski A, Karila L, Dolle F, Trichard C, Martinot J L. (2011).
Striatal and Extrastriatal Dopamine Transporter in Schizophrenia: A High Resolution PET Study.
Biol Psychiat. 69: 854. IF:08.674 [I2BM/SHFJ]
Auvin S, Chhun S, Berquin P, Ponchel E, Delanoe C, Chiron C. (2011).
Aggravation of absence seizure related to levetiracetam.
Eur J Paediatr Neurol. 15: 508-511. [I2BM/SHFJ]
Barcia G, Desguerre I, Barnerias C, Gitiaux C, Dulac O, Boddaert N, Nabbout R. (2011).
HEMICONVULSION-HEMIPLEGIA EPILEPSY (HHE) SYNDROME: LONGITUDINAL MRI FINDINGS IN 13 CHILDREN.
Epilepsia. 52: 178-178. IF:03,959 [I2BM/SHFJ]
Blockx I, Van Camp N, Verhoye M, Boisgard R, Dubois A, Jego B, Jonckers E, Raber K, Siquier K, Kuhnast B, Dolle F, Nguyen H P, Von Horsten S, Tavitian B, Van der Linden A. (2011).
Genotype specific age related changes in a transgenic rat model of Huntington's disease.
NeuroImage. 58: 1006-1016. IF:05.932 [I2BM/SHFJ I2BM/Mircen]
Boistel R, Swoger J, Krzic U, Fernandez V, Gillet B, Reynaud E G. (2011).
The future of three-dimensional microscopic imaging in marine biology.
Mar Ecol-Evol Persp. 32: 438-452. IF:01,272 [I2BM/SHFJ]
Bouillon-Pichault M, Nabbout R, Chhun S, Rey E, Chiron C, Dulac O, Pons G, Jullien V. (2011).
Topiramate pharmacokinetics in infants and young children: Contribution of population analysis.
Epilepsy Res. 93: 208-211. IF:02,302 [I2BM/SHFJ]
Cachia A, Carletti F, Woolley J, Picchioni M, Allen P, Krebs M, Martinot J, McGuire P. (2011).
SCALE RELATIONSHIP BETWEEN BRAIN VOLUME AND CORTEX AREA: AN ALLOMETRIC STUDY IN SUBJECTS AT RISK MENTAL STATE AND FIRST-EPISODE PSYCHOSIS PATIENTS.
Schizophr Bull. 37: 160-160. IF:08,273 [I2BM/SHFJ]
Cawthorne C, Prenant C, Smigova A, Julyan P, Maroy R, Herholz K, Rothwell N, Boutin H (2011).
Biodistribution, pharmacokinetics and metabolism of interleukin-1 receptor antagonist (IL-1RA) using [18F]-IL1RA and PET imaging in rats.
Br J Pharmacol. 162: 659-672. IF:05.204 [I2BM/SHFJ]
Cerutti E, Viale A, Damont A, Dolle F, Aime S. (2011).
Synthesis and testing of a p-H-2 hyperpolarized C-13 probe based on the pyrazolo[1,5-a]pyrimidineacetamide DPA-713, an MRI vector to target the peripheral benzodiazepine receptors.
Magn Reson Chem. 49: 795-800. IF:01.247 [I2BM/SHFJ]
Chauveau F, Boutin H, Van Camp N, Thominiaux C, Hantraye P, Rivron L, Marguet F, Castel M N, Rooney T, Benavides J, Dolle F, Tavitian B. (2011).
In vivo imaging of neuroinflammation in the rodent brain with [C-11]SSR180575, a novel indoleacetamide radioligand of the translocator protein (18 kDa).
Eur J Nucl Med Mol Imaging. 38: 509-514. IF:04.531 [I2BM/SHFJ I2BM/Mircen]
Chhun S, Troude P, Villeneuve N, Soufflet C, Napuri S, Motte J, Pouplard F, Alberti C, Helfen S, Pons G, Dulac O, Chiron C. (2011).
A prospective open-labeled trial with levetiracetam in pediatric epilepsy syndromes: Continuous spikes and waves during sleep is definitely a target.
Seizure. 20: 320-325. IF:01,649 [I2BM/SHFJ]
Chiron C. (2011).
Current therapeutic procedures in Dravet syndrome.
Dev Med Child Neurol. 53: 16-18. IF:03,264 [I2BM/SHFJ]
Chiron C, Dulac O. (2011).
EPILEPSY Vigabatrin treatment and visual field loss.
Nat Rev Neurol. 7: 189-190. IF:06,511 [I2BM/SHFJ]
Chiron C, Dulac O. (2011).
The pharmacologic treatment of Dravet syndrome.
Epilepsia. 52: 72-75. IF:03,955 [I2BM/SHFJ]
Coez A, Zilbovicius M, Ferrary E, Bouccara D, Mosnier I, Bozorg-Grayeli A, Ambert-Dahan E, Bizaguet E, Martinot J L, Samson Y, Sterkers O. (2011).
A neuro-imaging approach to evidencing bilateral cochlear implant advantages in auditory perception.
Cochlear Implants Int. 12 Suppl 1: S124-S126. IF:non répertorié [I2BM/SHFJ]
Damont A, Boisgard R, Kuhnast B, Lemee F, Raggiri G, Scarf A M, Da Pozzo E, Selleri S, Martini C, Tavitian B, Kassiou M, Dolle F. (2011).
Synthesis of 6-[(18)F]fluoro-PBR28, a novel radiotracer for imaging the TSPO 18 kDa with PET.
Bioorg Med Chem Lett. 21: 4819-4822. IF:02,661 [I2BM/SHFJ]
Damont A, Sik-chung Alex C, Medran-Navarrete V, Kuhnast B, Gaudy H, Dolle F. (2011).
Synthesis and fluorine-18 labelling of a novel pyrazolo[1,5-a]pyrimidineacetamide, CfO-DPA-714, a compound devoid of the metabolically unstable fluoroalkoxy moiety.
J Label Compd Radiopharm. 54: S461-S461. IF:01,096 [I2BM/SHFJ]
Damont A, Le Helleix S, Kuhnast B, Boisgard R, Marguet F, Puech F, Tavitian B, Dolle F. (2011).
Synthesis and carbon-11-labeling of p-MeO-SSR180575, a novel indoleacetamide-based candidate for PET imaging of the peripheral benzodiazepine receptor (TSPO 18 kDa).
J Label Compd Radiopharm. 54: S264-S264. IF:1,096 [I2BM/SHFJ]
Damont A, Catarina T, Kuhnast B, Boisgard R, Marguet F, Puech F, Rooney T, Tavitian B, Dolle F. (2011).
Novel [(18)F]fluoroethoxy- and [(18)F]fluoropropoxyindoleacetamides for imaging the TSPO 18kDa (PBR) with PET.
J Label Compd Radiopharm. 54: S34-S34. IF:01,096 [I2BM/SHFJ]
Dolle F, Kuhnast B, Damont A, Van Camp N, Kassiou M, Tavitian B, Boisgard R. (2011).
[(18)F]DPA-716 as a candidate for imaging the TSPO 18 kDa with PET: Radiosynthesis and comparative evaluation ([(11)C]DPA-713/[(18)F]DPA-714) in a rat model of neuroinflammation.
J Label Compd Radiopharm. 54: S275-S275. IF:01,096 [I2BM/SHFJ]
Dolle F, Demphel S, Saba W, Schollhorn-Peyronneau MA, Charton Y, Goldstein S, Deverre JR, Bottlaender M, Lestage P, Valette H. (2011).
Carbon-11 labelling of S38419, a novel alpha-4-beta-2-selective ligand for PET imaging of nicotinic acetylcholine receptors.
J Label Compd Radiopharm. 54: S272-S272. IF:01,096 [I2BM/SHFJ]
Dolle F, Le Helleix S, Schollhorn-Peyronneau MA, Saba W, Banister S, Tournier N, Valette H, Kassiou M. (2011).
Carbon-11-labelling of a novel, trishomocubane-derived, high affinity and selectivity DAT ligand.
J Label Compd Radiopharm. 54: S276-S276. IF:01,096 [I2BM/SHFJ]
Dolle F, Le Helleix S, Demphel S, Bramoulle Y, Hinnen F, de Bruin B, Brasseur D, Deverre JR, Bottlaender M, Grosjean P. (2011).
Radiosynthesis of [(11)C]SSR126374, a new selective CRF(1) antagonist.
J Label Compd Radiopharm. 54: S273-S273. IF:01,096 [I2BM/SHFJ]
Dolle F, Bramoulle Y, Deverre JR, Bottlaender M, Passchier J. (2011).
Radiosynthesis of [(11)C]SB-705498, a selective transient receptor potential Vanilloid 1 (TRPV1) receptor antagonist.
J Label Compd Radiopharm. 54: S93-S93. IF:01,096 [I2BM/SHFJ]
Dorfmuller G, Rodrigo S, Fohlen M, Ferrand-Sorbets S, Blustajn J, Taussig D, Bulteau C, Delalande O. (2011).
RADIO-ANATOMICAL LOCALIZATION OF THE FORAMEN OVALE ELECTRODE IN CHILDREN WITH TEMPORAL LOBE EPILEPSY.
Epilepsia. 52: 192-192. IF:03,955 [I2BM/SHFJ]
Drake C, Boutin H, Jones M S, Denes A, McColl B W, Selvarajah J R, Hulme S, Georgiou R F, Hinz R, Gerhard A, Vail A, Prenant C, Julyan P, Maroy R, Brown G, Smigova A, Herholz K, Kassiou M, Crossman D, Francis S, Proctor S D, Russell J C, Hopkins S J, Tyrrell P J, Rothwell N J, Allan S M. (2011).
Brain inflammation is induced by co-morbidities and risk factors for stroke.
Brain Behav Immun. 25: 1113-1122. IF:03,956 [I2BM/SHFJ]
Duchesnay E, Cachia A, Boddaert N, Chabane N, Mangin J F, Martinot J L, Brunelle F, Zilbovicius M. (2011).
Feature selection and classification of imbalanced datasets: application to PET images of children with autistic spectrum disorders.
NeuroImage. 57: 1003-1014. IF:05,932 [I2BM/Neurospin I2BM/SHFJ]
Hernandez A I, Le Rolle V, Ojeda D, Baconnier P, Fontecave-Jallon J, Guillaud F, Grosse T, Moss R G, Hannaert P, Thomas R. (2011).
Integration of detailed modules in a core model of body fluid homeostasis and blood pressure regulation.
Prog Biophys Mol Biol. 107: 169-182. IF:03,964 [I2BM/SHFJ]
Jan S, Benoit D, Becheva E, Carlier T, Cassol F, Descourt P, Frisson T, Grevillot L, Guigues L, Maigne L, Morel C, Perrot Y, Rehfeld N, Sarrut D, Schaart D R, Stute S, Pietrzyk U, Visvikis D, Zahra N, Buvat I. (2011).
GATE V6: a major enhancement of the GATE simulation platform enabling modelling of CT and radiotherapy.
Phys Med Biol. 56: 881-901. IF:02.781 [I2BM/SHFJ]
Jones T, Price P, Tavitian B. (2011).
Realizing the Full Potential of PET for Measuring the Biodistribution of Novel Anticancer Agents.
J Nucl Med. 52: 1500. IF:07,022 [I2BM/SHFJ]
Kuhnast B, Damont A, Tournier N, Saba W, Valette H, Bottlaender M, Dolle F. (2011).
Radiosynthesis of [(11)C]glyburide for in vivo imaging of BCRP function with PET.
J Label Compd Radiopharm. 54: S262-S262. IF:01,096 [I2BM/SHFJ]
Kuhnast B, Hinnen F, Mackiewicz N, Tavitian B, Gravel E, Doris E, Duconge F, Dolle F. (2011).
Fluorine-18-labeling of polymerized nanomicelles for in vivo PET imaging.
J Label Compd Radiopharm. 54: S532-S532. IF:01,096 [I2BM/SHFJ]
Kuhnast B, Hinnen F, Boisgard R, Nielsen P, Tavitian B, Dolle F. (2011).
Fluorine-18 labeling of a novel series of chimeric, mdm2 oncogene-targeting, peptide-pna oligomers using [(18)F]FPyME.
J Label Compd Radiopharm. 54: S6-S6. IF:01,096 [I2BM/SHFJ]
Kuhnast B, Boisgard R, El Hadri A, Hinnen F, Richard S, Caravano A, Petitou M, Tavitian B, Dolle F. (2011).
Fluorine-18 labeling using [(18)F]FPyME of a small-glyco drug for potential applications in oncology.
J Label Compd Radiopharm. 54: S176-S176. IF:01,096 [I2BM/SHFJ]
de Langavant L C, Remy P, Trinkler I, McIntyre J, Dupoux E, Berthoz A, Bachoud-Levi A C. (2011).
Behavioral and Neural Correlates of Communication via Pointing.
PLoS ONE. 6: 10. IF:fi [I2BM/SHFJ]
Lebenberg J, Herard A S, Dubois A, Dhenain M, Hantraye P, Delzescaux T. (2011).
A combination of atlas-based and voxel-wise approaches to analyze metabolic changes in autoradiographic data from Alzheimer's mice.
NeuroImage. 57: 1447-1457. IF:05,932 [I2BM/SHFJ I2BM/Mircen]
Lebre A S, Rio M, d'Arcier L F, Vernerey D, Landrieu P, Slama A, Jardel C, Laforet P, Rodriguez D, Dorison N, Galanaud D, Chabrol B, Paquis-Flucklinger V, Grevent D, Edvardson S, Steffann J, Funalot B, Villeneuve N, Valayannopoulos V, De Lonlay P, Desguerre I, Brunelle F, Bonnefont J P, Rotig A, Munnich A, Boddaert N. (2011).
A common pattern of brain MRI imaging in mitochondrial diseases with complex I deficiency.
J Med Genet. 48: 16-23. IF:07,037 [I2BM/SHFJ]
Lerat H, Higgs M, Gaudin A, Cohen C, Merour E, Boisgard R, Tavitian B, Kammoun H L, Hainault I, Blondeau B, Foufelle F, Pawlotsky J M. (2011).
HEPATITIS C VIRUS INDUCES TYPE 2 DIABETES THROUGH DEREGULATION OF INSULIN SECRETION AND GLUCOSE TRANSPORT.
Hepatology. 54: 1311A-1311A. IF:10,885 [I2BM/SHFJ]
Leroy C, Karila L, Martinot J L, Lukasiewicz M, Duchesnay E, Comtat C, Dolle F, Benyamina A, Artiges E, Ribeiro M J, Reynaud M, Trichard C. (2011).
Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study.
Addict Biol. sous presse: IF:04,152 [I2BM/SHFJ I2BM/Neurospin]
Liu T, Liu J, de Rochefort L, Spincemaille P, Khalidov I, Ledoux J R, Wang Y. (2011).
Morphology Enabled Dipole Inversion (MEDI) from a Single-Angle Acquisition: Comparison with COSMOS in Human Brain Imaging.
Magn Reson Med. 66: 777-783. IF:03,268 [I2BM/SHFJ]
Mackiewicz N, Gravel E, Garofalakis A, Ogier J, John J, Dupont D M, Gombert K, Tavitian B, Doris E, Duconge F. (2011).
Tumor-Targeted Polydiacetylene Micelles for In Vivo Imaging and Drug Delivery.
Small. 7: 2786-2792. IF:07,333 [iBiTec-S/SCBM I2BM/SHFJ]
Maisonial A, Kuhnast B, Papon J, Boisgard R, Bayle M, Vidal A, Auzeloux P, Rbah L, Bonnet-Duquennoy M, Miot-Noirault E, Galmier M J, Borel M, Askienazy S, Dolle F, Tavitian B, Madelmont J C, Moins N, Chezal J M. (2011).
Single Photon Emission Computed Tomography/Positron Emission Tomography Imaging and Targeted Radionuclide Therapy of Melanoma: New Multimodal Fluorinated and Iodinated Radiotracers.
J Med Chem. 54: 2745-2766. IF:05,207 [I2BM/SHFJ]
Mantoulan C, Payoux P, Diene G, Glattard M, Roge B, Molinas C, Sevely A, Zilbovicius M, Celsis P, Tauber M. (2011).
PET scan perfusion imaging in the Prader-Willi syndrome: new insights into the psychiatric and social disturbances.
J Cereb Blood Flow Metab. 31: 275-282. IF:05.457 [I2BM/SHFJ]
Marchant I, Nony P, Cucherat M, Boissel J P, Thomas S R, Bejan-Angoulvant T, Laugerotte A, Kahoul R, Gueyffier F. (2011).
The Global Risk Approach Should Be Better Applied in French Hypertensive Patients: A Comparison between Simulation and Observation Studies.
PLoS ONE. 6: 7. IF:04,411 [I2BM/SHFJ]
Martin A, Boisgard R, Kassiou M, Dolle F, Tavitian B. (2011).
Reduced PBR/TSPO Expression After Minocycline Treatment in a Rat Model of Focal Cerebral Ischemia: A PET Study Using [F-18]DPA-714.
Mol Imaging Biol. 13: 10-15. IF:02.467 [I2BM/SHFJ]
Martin A, Garofalakis A, Tavitian B. (2011).
In Vivo Evidence that the Increase in Matrix Metalloproteinase Activity Occurs Early after Cerebral Ischemia.
Mol Imaging Biol. sous presse: IF:3,169 [I2BM/SHFJ]
Martinot J L, Mana S. (2011).
Neuroimaging of psychiatric and pedopsychiatric disorders.
M S-Med Sci. 27: 639-650. IF:00,486 [I2BM/SHFJ]
Mazzuca M, Jambaque I, Hertz-Pannier L, Bouilleret V, Archambaud F, Caviness V, Rodrigo S, Dulac O, Chiron C. (2011).
F-18-FDG PET Reveals Frontotemporal Dysfunction in Children with Fever-Induced Refractory Epileptic Encephalopathy.
J Nucl Med. 52: 40-47. IF:06.424 [I2BM/SHFJ]
Merian J, Boisgard R, Decleves X, Boisseau P, Texier I, Tavitian B. (2011).
Pharmacokinetics and biodistribution in FVB mice of radioactive and fluorescent triply-labeled lipid nanoparticles.
Bull Cancer. 98: 77. IF:00,887 [I2BM/SHFJ]
Mignot C, Moutard M L, Trouillard O, Gourfinkel-An I, Jacquette A, Arveiler B, Morice-Picard F, Lacombe D, Chiron C, Ville D, Charles P, LeGuern E, Depienne C, Heron D. (2011).
STXBP1-related encephalopathy presenting as infantile spasms and generalized tremor in three patients.
Epilepsia. 52: 1820-1827. IF:03,955 [I2BM/SHFJ]
Nabbout R, Vezzani A, Dulac O, Chiron C. (2011).
Acute encephalopathy with inflammation-mediated status epilepticus.
Lancet Neurol. 10: 99-108. IF:21,659 [I2BM/SHFJ]
Nabbout R, Copioli C, Chipaux M, Chemaly N, Desguerre I, Dulac O, Chiron C. (2011).
Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: A prospective pilot study.
Epilepsia. 52: E54-E57. IF:03,955 [I2BM/SHFJ]
Paillère-Martinot ML, Martinot J L, Ringuenet D, Galinowski A, Gallarda T, Bellivier F, Lefaucheur J P, Lemaitre H, Artiges E. (2011).
Baseline Brain Metabolism in Resistant Depression and Response to Transcranial Magnetic Stimulation.
Neuropsychopharmacology. Sous presse: IF:08,674 [I2BM/SHFJ]
Plaze M, Paillère-Martinot ML, Penttilä J, Januel D, de Beaurepaire R, Bellivier F, Andoh J, Galinowski A, Gallarda T, Artiges E, Olié JP, Mangin JF, Martinot JL, Cachia A. (2011).
"Where Do Auditory Hallucinations Come From?"--A Brain Morphometry Study of Schizophrenia Patients With Inner or Outer Space Hallucinations.
Schizophr Bull. 37: 212-221. IF:07,467 [I2BM/Neurospin I2BM/SHFJ]
de Pontual L, Kettaneh D, Gordon C T, Oufadem M, Boddaert N, Lees M, Balu L, Lachassinne E, Petros A, Mollet J, Wilson L C, Munnich A, Brugiere L, Delattre O, Vekemans M, Etchevers H, Lyonnet S, Janoueix-Lerosey I, Amiel J. (2011).
Germline Gain-of-Function Mutations of ALK Disrupt Central Nervous System Development.
Hum Mutat. 32: 272-276. IF:05,956 [I2BM/SHFJ]
Roeda D, Kuhnast B, Damont A, Cerutti E, Dolle F. (2011).
Towards nonafluorobutane-1-sulphonyl [(18)F]fluoride as a (18)F for OH radiofluorinating agent at the no-carrier-added level - Some initial experimental observations.
J Label Compd Radiopharm. 54: S504-S504. IF:01,096 [I2BM/SHFJ]
Salvadore G, Nugent A C, Lemaitre H, Luckenbaugh D A, Tinsley R, Cannon D M, Neumeister A, Zarate C A, Drevets W C. (2011).
Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder.
NeuroImage. 54: 2643-2651. IF:05,937 [I2BM/SHFJ]
de Souza L C, Corlier F, Habert M O, Uspenskaya O, Maroy R, Lamari F, Chupin M, Lehericy S, Colliot O, Hahn-Barma V, Samri D, Dubois B, Bottlaender M, Sarazin M. (2011).
Similar amyloid-beta burden in posterior cortical atrophy and Alzheimer's disease.
Brain. 134: 2036-2043. IF:09,230 [I2BM/SHFJ]
Stankoff B, Freeman L, Aigrot M S, Chardain A, Dolle F, Williams A, Galanaud D, Armand L, Lehericy S, Lubetzki C, Zalc B, Bottlaender M. (2011).
Imaging Central Nervous System Myelin by Positron Emission Tomography in Multiple Sclerosis Using [Methyl-C-11]-2-(4 '-Methylaminophenyl)-6-Hydroxybenzothiazole.
Ann Neurol. 69: 673-680. IF:10,746 [I2BM/SHFJ]
Thivard L, Bouilleret V, Chassoux F, Adam C, Dormont D, Baulac M, Semah F, Dupont S. (2011).
Diffusion tensor imaging can localize the epileptogenic zone in nonlesional extra-temporal refractory epilepsies when [(18)F]FDG-PET is not contributive.
Epilepsy Res. 97: 170-182. IF:02,302 [I2BM/SHFJ]
Tournier N, Valette H, Peyronneau M A, Saba W, Goutal S, Kuhnast B, Dolle F, Scherrmann J M, Cisternino S, Bottlaender M. (2011).
Transport of Selected PET Radiotracers by Human P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2): An In Vitro Screening.
J Nucl Med. 52: 415-423. IF:06.424 [I2BM/SHFJ]
Tournier N, Decleves X, Saubamea B, Scherrmann J M, Cisternino S. (2011).
Opioid Transport by ATP-Binding Cassette Transporters at the Blood-Brain Barrier: Implications for Neuropsychopharmacology.
Curr Pharm Design. 17: 2829-2842. IF:04.774 [I2BM/SHFJ]
Vasdev N, Sadovski O, Garcia A, Dolle F, Meyer J H, Houle S, Wilson A A. (2011).
Radiosynthesis of [(11)C]SL25.1188 via [(11)C]CO(2) fixation for imaging monoamine oxidase B.
J Label Compd Radiopharm. 54: 678-680. IF:01,096 [I2BM/SHFJ]Lien vers le web
Vasdev N, Sadovski O, Garcia A, Dolle F, Meyer J H, Houle S, Wilson A A. (2011).
A simplified radiosynthesis of [(11)C]SL25.1188 for imaging monoamine oxidase-B.
J Label Compd Radiopharm. 54: S104-S104. IF:01,096 [I2BM/SHFJ]
Zanotti-Fregonara P, Liow J S, Fujita M, Dusch E, Zoghbi S S, Luong E, Boellaard R, Pike V W, Comtat C, Innis R B. (2011).
Image-Derived Input Function for Human Brain Using High Resolution PET Imaging with [C-11](R)-rolipram and [C-11]PBR28.
PLoS ONE. 6: 11. IF:04.383 [I2BM/SHFJ]
Zheng J Z, Boisgard R, Siquier-Pernet K, Decaudin D, Dolle F, Tavitian B. (2011).
Differential Expression of the 18 kDa Translocator Protein (TSPO) by Neoplastic and Inflammatory Cells in Mouse Tumors of Breast Cancer.
Mol Pharm. 8: 823-832. IF:05,400 [I2BM/SHFJ]
Zueva E, Rubio LI, Ducongé F, Tavitian B. (2011).
Metastasis-focused cell-based SELEX generates aptamers inhibiting cell migration and invasion.
Int J Cancer. 128: 797-804. IF:04,722 [I2BM/SHFJ